Alessandra Mazzola

Alessandra Mazzola

Auto-generated profile, based on publicly available information

Alessandra Mazzola

Sorbonne Université, Unité Médicale de Transplantation Hépatique, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Clinics and Research in Hepatology and Gastroenterology
Verified
Journal Article
Closed access
AMAlessandra Mazzola
Alessandra Mazzola
BMBianca Magro
Bianca Magro
FPFabiano Perdigao
Fabiano Perdigao
FCFréderic Charlotte
Fréderic Charlotte
MAMuhammad Atif
Muhammad Atif
FCFilomena Conti
Filomena Conti

1 February 2008 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
AMA. Mazzola
A. Mazzola
CMC. Meazza
C. Meazza
PTP. Travaglino
P. Travaglino
SPS. Pagani
S. Pagani
DFD. Frattini
D. Frattini
MBMauro Bozzola
Mauro Bozzola

28 November 2020 in World Journal of Gastroenterology
Verified
Journal Article
Open access
ASAnna Sessa
Anna Sessa
AMAlessandra Mazzola
Alessandra Mazzola
CLChetana Lim
Chetana Lim
MAMohammed Atif
Mohammed Atif
JPJuliana Pappatella
Juliana Pappatella
FCFilomena Conti
Filomena Conti
Coronavirus disease (COVID) is a new and highly contagious infectious disease caused by the coronavirus (COVID-19 or severe acute respiratory syndrome coronavirus 2). There is limited data regarding the incidence and management of COVID-19 in immunocompromised patients’ post-transplantation. In the pre-COVID-19 era, these patients were already at an increased risk of developing opportunistic infections. These often manifested with atypical symptoms. We report another case of uneventful COVID-19 pneumonia in a 58-year old male who was 18 mo’ post liver transplantation. He received tacrolimus monotherapy since July 2019. The clinical manifestations included only epigastric pain radiating to the right hypochondrium, nausea and vomiting. He had no fevers, cough, shortness of breath, anosmia or dysgeusia even if the chest computed tomography scan revealed an extension of the multiple patchy ground-glass density shadows to the upper lobe of the left lung too. He was hospitalised and received a course of oral chloroquine (200 mg × 3 per day) for a period of 10 d. Interestingly, the COVID 19 infection was uneventful though there were no modifications to his tacrolimus dosing. He was successfully discharged. We performed subsequent follow-up via telemedicine. In light of the current pandemic, it is even more important to identify how the liver recipient’s patients present and are managed, especially for immuno-suppression treatment.

26 February 2018 in Clinical Microbiology and Infection
Verified
Journal Article
Open access
PDF file
AMA. Mazzola
A. Mazzola
MMM. Tran Minh
M. Tran Minh
SJS. Jauréguiberry
S. Jauréguiberry
DBD. Bernard
D. Bernard
PLP. Lebray
P. Lebray
FCF. Conti
F. Conti

1 September 2020 in Clinics and Research in Hepatology and Gastroenterology
Verified
Journal Article
Closed access
AMAlessandra Mazzola
Alessandra Mazzola
FKFrançois Kerbaul
François Kerbaul
MAMuhammad Atif
Muhammad Atif
AMAntoine Monsel
Antoine Monsel
GMGéraldine Malaquin
Géraldine Malaquin
FCFilomena Conti
Filomena Conti

1 October 2018 in Clinics and Research in Hepatology and Gastroenterology
Verified
Journal Article
Closed access
AMA. Mazzola
A. Mazzola
FPF. Perdigao
F. Perdigao
STS. Tripon
S. Tripon
YCY. Calmus
Y. Calmus
MWM. Wagner
M. Wagner
FCF. Conti
F. Conti